Prediabetes and Type 2 Diabetes Data Collection Study
NCT04503239 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 306
Last updated 2021-10-05
Summary
To collect data in an observational study from Prediabetes (PD) and Type 2 Diabetes (T2D) patients including time correlated CGM, medication and food intake approximately 80% of the time for each subject that completes the entire active phase.
Conditions
- Diabetes Mellitus, Type 2
- Pre-diabetes
Interventions
- DEVICE
-
G6
Wear 9 wear periods of the 10-day CGM
Sponsors & Collaborators
-
DexCom, Inc.
lead INDUSTRY
Principal Investigators
-
Danny Chernavvsky, MD · DexCom, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-22
- Primary Completion
- 2022-02-27
- Completion
- 2022-02-27
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm
NCT02087995 ·Status: COMPLETED ·Phase: NA
-
Diabetes Connect: Patients and Providers Use of a Secure Website for Blood Glucose Monitoring in Type-2 Diabetes
NCT00812539 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring in Diabetes and Prediabetes
NCT03805412 ·Status: COMPLETED ·Phase: NA
-
Pivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic Setting
NCT00925080 ·Status: COMPLETED
-
Precision Nutrition Versus Standard Dietary Care: Continuous Glucose Monitoring as a Tool for Guided Nutrition Care in Type 2 Diabetes - The PRECISE-DIET Trial. -A Pilot Study
NCT06832059 ·Status: RECRUITING ·Phase: NA
-
Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)
NCT06483945 ·Status: RECRUITING
-
Data Acquisition to Model Glycemic Response
NCT03612999 ·Status: COMPLETED ·Phase: NA
-
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
NCT01548222 ·Status: COMPLETED
-
Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 Diabetes
NCT03207893 ·Status: COMPLETED ·Phase: NA
-
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
NCT07197788 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dexcom G6 Observational Study
NCT03832907 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes
NCT05523362 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System
NCT02880267 ·Status: COMPLETED ·Phase: NA
-
Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform
NCT04369833 ·Status: COMPLETED
-
Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT04540536 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics
NCT03252964 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of the Feasibility and Accuracy of the TrueVie CGM System - A Non-Significant Risk Study
NCT05348928 ·Status: COMPLETED
-
Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System
NCT00722241 ·Status: COMPLETED
-
Dexcom G6 Intervention Study
NCT03877068 ·Status: COMPLETED ·Phase: NA
-
Dexcom Continuous Glucose Monitoring in Long-term Care
NCT04818242 ·Status: COMPLETED ·Phase: NA
-
The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes
NCT01741467 ·Status: COMPLETED ·Phase: NA
-
Community Glucose Monitoring Project
NCT05351190 ·Status: UNKNOWN ·Phase: NA
-
Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System
NCT04529239 ·Status: COMPLETED
-
Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk
NCT01727349 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)
NCT03290768 ·Status: COMPLETED ·Phase: NA